| NCT ID | NCT05242861 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhejiang Cancer Hospital |
| Condition | Brachytherapy |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-02-20 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-02-20 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Brachytherapy for gynecological cancers will be studied retrospectively.
Eligibility Criteria
Inclusion Criteria: * 18 - 80 female * Underwent brachytherapy * With gynecological cancer Exclusion Criteria: * Refusal to enter this trial
Frequently Asked Questions
Who can join the NCT05242861 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Brachytherapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05242861 currently recruiting?
Yes, NCT05242861 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zhejiang Cancer Hospital to inquire about joining.
Where is the NCT05242861 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT05242861 clinical trial?
NCT05242861 is sponsored by Zhejiang Cancer Hospital. The trial plans to enroll 300 participants.